top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Controversy only exists as to whether LDL cholesterol target levels or risk-adjusted dosing should be used in their management,5 with the former advocated by the European Society of Cardiology and ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/02/2015 Item size : 212610 bytes
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/02/2016